These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2157579)

  • 1. Empirical Bayes estimates of subgroup effects in clinical trials.
    Davis CE; Leffingwell DP
    Control Clin Trials; 1990 Feb; 11(1):37-42. PubMed ID: 2157579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else.
    Varadhan R; Wang SJ
    Biom J; 2016 Jan; 58(1):133-53. PubMed ID: 26485117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation issues in clinical trials and overviews.
    Pocock SJ; Hughes MD
    Stat Med; 1990 Jun; 9(6):657-71. PubMed ID: 2145623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stopping rules and estimation problems in clinical trials.
    Hughes MD; Pocock SJ
    Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical Bayes approach for subgroup analysis.
    Hsu YY; Zalkikar J; Tiwari RC
    Stat Methods Med Res; 2019 Jan; 28(1):275-288. PubMed ID: 28747088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian approach to the interpretation of subgroup results in clinical trials.
    Donner A
    J Chronic Dis; 1982; 35(6):429-35. PubMed ID: 7076786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating baseline values of the variable of intervention in a clinical trial.
    Knoke JD; Hawkins DL
    Control Clin Trials; 1985 Jun; 6(2):136-45. PubMed ID: 4006487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive power priors with empirical Bayes for clinical trials.
    Gravestock I; Held L;
    Pharm Stat; 2017 Sep; 16(5):349-360. PubMed ID: 28574202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian approach to subgroup identification.
    Berger JO; Wang X; Shen L
    J Biopharm Stat; 2014; 24(1):110-29. PubMed ID: 24392981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible shrinkage estimation of subgroup effects through Dirichlet process priors.
    Gamalo-Siebers M; Tiwari R; LaVange L
    J Biopharm Stat; 2016; 26(6):1040-1055. PubMed ID: 27548701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-centre trial analysis revisited.
    Gould AL
    Stat Med; 1998 Aug 15-30; 17(15-16):1779-97; discussion 1799-800. PubMed ID: 9749447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in bayes and empirical bayes methods: estimating parameters, populations and ranks.
    Louis TA; Shen W
    Stat Med; 1999 Sep 15-30; 18(17-18):2493-505. PubMed ID: 10474155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projection from previous studies. A caution.
    Korn EL
    Control Clin Trials; 1990 Feb; 11(1):67-9. PubMed ID: 2157583
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of "shrinkage" in subgroup analyses.
    Lipsky AM; Gausche-Hill M; Vienna M; Lewis RJ
    Ann Emerg Med; 2010 Jun; 55(6):544-552.e3. PubMed ID: 20138396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical Bayes interval estimates that are conditionally equal to unadjusted confidence intervals or to default prior credibility intervals.
    Bickel DR
    Stat Appl Genet Mol Biol; 2012 Feb; 11(3):Article 7. PubMed ID: 22499708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian subgroup analysis with a zero-enriched Polya Urn scheme.
    Sivaganesan S; Laud PW; Müller P
    Stat Med; 2011 Feb; 30(4):312-23. PubMed ID: 21225894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model averaging for treatment effect estimation in subgroups.
    Bornkamp B; Ohlssen D; Magnusson BP; Schmidli H
    Pharm Stat; 2017 Mar; 16(2):133-142. PubMed ID: 27935199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting qualitative interaction: a Bayesian approach.
    Bayman EO; Chaloner K; Cowles MK
    Stat Med; 2010 Feb; 29(4):455-63. PubMed ID: 19950107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring clinical trials based on predictive probability of significance.
    Choi SC; Pepple PA
    Biometrics; 1989 Mar; 45(1):317-23. PubMed ID: 2720057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.